TRH analog MK-771 reverses neurochemical and learning deficits in medial septal-lesioned rats

Peptides. 1989 Jan-Feb;10(1):121-4. doi: 10.1016/0196-9781(89)90087-9.

Abstract

Microinjection of ibotenic acid into medial septum of rats decreased choline acetyltransferase (CAT) and high-affinity choline uptake (HACU) activities in hippocampus and retarded the learning of a spatial memory task in the radial-arm maze. Administration of MK-771, a stable TRH analog, to such animals restored HACU activity in hippocampus to normal levels. Daily treatment of rats with MK-771 prior to maze running also restored the animals' learning ability. MK-771 did not enhance hippocampal HACU activity or maze performance in sham-lesioned rats. These results suggest that MK-771 reversed the ibotenic acid-induced memory deficit by restoring septohippocampal cholinergic function. MK-771 and other TRH analogs may represent novel agents for improving memory deficits produced by cholinergic insufficiency in Alzheimer's disease.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antidepressive Agents / pharmacology*
  • Choline O-Acetyltransferase / metabolism*
  • Hippocampus / drug effects
  • Hippocampus / enzymology
  • Hippocampus / physiology*
  • Ibotenic Acid / pharmacology
  • Learning / drug effects*
  • Male
  • Rats
  • Rats, Inbred Strains
  • Reference Values
  • Thiazolidines
  • Thyrotropin-Releasing Hormone / analogs & derivatives*
  • Thyrotropin-Releasing Hormone / pharmacology

Substances

  • Antidepressive Agents
  • Thiazolidines
  • Ibotenic Acid
  • Thyrotropin-Releasing Hormone
  • pyro(l-alpha-aminoadipyl)-L-histidyl-L-thiazolidine-4-carboxamide
  • Choline O-Acetyltransferase